OMZ Financial Statements (OMZZ)

ОМЗsmart-lab.ru %   2022Q4 2023Q1 2023Q2 2023Q3 2023Q4   LTM ?
Report date 11.04.2023 31.08.2023 01.04.2024   01.04.2024
Currency RUB RUB RUB RUB RUB   RUB
Financial report URL  
Revenue, bln rub ? 8.95 8.00 18.0   26.0
Operating Income, bln rub -1.57 -0.923 1.07   0.150
EBITDA, bln rub ? -0.640   -0.640
Net profit, bln rub ? 1.47 0.940 2.52   3.46
OCF, bln rub ? 0.125 0.255   0.380
CAPEX, bln rub ? 1.24 0.760   2.00
FCF, bln rub ? 4.62 -6.52   -1.90
Ordinary share dividend yield, % 0.0% 0.0% 0.0% 0.0% 0.0%   0
Preferred share dividend yield, % 0.0% 0.0% 0.0% 0.0% 0.0%   0
Dividend payout ratio, % 0% 0% 0%   0
OPEX, bln rub 2.10 1.43 3.09   4.52
Cost of production, bln rub 8.38 7.50 13.8   21.3
Interest expenses, bln rub 0.890 1.43   2.32
Assets, bln rub 54.3 62.8 73.7   73.7
Net Assets, bln rub ? 25.0 25.8 30.2   30.2
Debt, bln rub 18.2 20.5 22.4   22.4
Cash, bln rub 11.0 16.7 9.50   9.50
Net debt, bln rub 7.20 0.00 3.80 0.00 12.9   12.9
Ordinary share price, rub 4 995 11 650 10 195 17 045 13 700   13 700
Number of ordinary shares, mln 1 784 1 784 1 784 1 784 1 784   1 784
Preferred share price, rub 4 995 11 650 10 195 17 045 13 700   17 800
Number of preferred shares, mln 2.75 2.75 2.75 2.75 2.75   2.75
Market cap, bln rub 8 926 20 819 18 219 30 461 24 483   24 494
EV, bln rub ? 8 934 20 819 18 223 30 461 24 496   24 507
Book value, bln rub 24.7 0.00 21.6 0.00 25.8   25.8
EPS, rub ? 0.82 0.00 0.53 0.00 1.41   1.94
FCF/share, rub 0.00 0.00 2.59 0.00 -3.65   -1.06
BV/share, rub 13.8 0.00 12.1 0.00 14.5   14.5
EBITDA margin, % ? 0.0% -8.0% 0.0%   -2.5%
Net margin, % ? 16.4% 11.8% 14.0%   13.3%
FCF yield, % ? -0.1% -0.1% 0.0% 0.0% 0.0%   0.0%
ROE, % ? 53.9% 9.3% 11.4%   11.4%
ROA, % ? 24.8% 3.8% 4.7%   4.7%
P/E ? 662.7 1 546 7 560 12 639 7 076   7 079
P/FCF -806.4 -1 881 3 944 6 593 -12 886   -12 892
P/S ? 469.8 1 096 1 075 1 797 941.7   942.1
P/BV ? 361.4 843.5 948.6   949.0
EV/EBITDA ? -13 959 -32 530 -28 474 -47 595 -38 275   -38 292
Debt/EBITDA -11.3 0.00 -5.94 0.00 -20.2   -20.2
R&D/CAPEX, % 0.00% 0.00%   0
CAPEX/Revenue, % 0% 16% 4%   8%
OMZ shareholders